Pharmacelsus is early stage CRO specialized in planning and realizing customized preclinical studies for more than 20 years. We supports the entire process of preclinical drug discovery and development testing program, including pharmacokinetics, pharmacodynamics, and toxicology in order to predict the risk of harmful reactions and help you to choose the most suitable candidate for clinical trials.
Using leading-edge multi-array technologies we offer multiplex high-throughput detection, quantification and characterization of Biomarkers (cytokines, hormones, enzymes) and Biopharmaceuticals (e.g. monoclonal antibodies) in different biological matrices from pre-clinical (non-GLP/GLP) as well as clinical studies (GCLP).
Our assays validation and analysis meet national and international regulatory demands.